Table 1.
Characteristics of the study populations in the included studies.
| First author, year, and reference | Ethnicity | Gender | Age | Study population | Outcome |
|---|---|---|---|---|---|
| Sousa 2009 [10] | Brazil | M/F | 58.4–62.7 | Nondiabetic subjects, diabetic subject | TC, LDL-c, HDL-c, TG |
| Muendlein 2011 [12] | Austria | M/F | 63.3–65.9 | Diabetic subject, nondiabetic subjects | TC, LDL-c, HDL-c, TG |
| Palizban 2012 [13] | Iran | M/F | 50.4–59.3 | Diabetic subject, nondiabetic subjects | TC, TG |
| Then 2013 [14] | German | M | 51–58 | Nondiabetic subjects | TC, LDL-c, HDL-c, TG |
| Kahveci 2012 [15] | Turkey | M/F | 36–84 | Diabetic subject and nondiabetic subjects | TC, LDL-c, HDL-c, TG |
| Bodhini 2007 [16] | Asian Indians | M/F | 41 ± 11 | Normal glucose tolerant subjects | TC, LDL-c, HDL-c, TG |
| Warodomwichit 2009 [9] | European Americans | M/F | 17–92 ys | The Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study | TC, LDL-c, HDL-c, TG |
| Melzer 2006 [11] | White European origin | M/F | ≥65 ys | Older population from InCHIATI study | TC, LDL-c, HDL-c, TG |
| Marquezine 2008 [17] | Brazil | M/F | 44.3–59.8 | Multivessel coronary artery disease patients, general population | TC, HDL-c, TG |
| Musso 2009 [18] | Italy | M/F | 38–41 | Healthy control, nonalcoholic fatty liver disease | TC, LDL-c, HDL-c, TG |
| Choi 2014 [19] | Korea | M/F | 59-60 | Diabetic patients | TC, LDL-c, HDL-c, TG |
| Wang 2013 [20] | Chinese | M/F | 20–85 | Nondiabetic controls | TC, LDL-c, HDL-c, TG |
| Delgado-Lista 2011 [21] | LIPGENE dietary intervention from 8 European countries | M/F | 35–70 ys | Metabolic syndrome according to NCEP criteria | TC, LDL-c, HDL-c, TG |
| Perez-Martinez 2012 [8] | Ireland | M/F | 22–68.4 | Young men, metabolic syndrome, and healthy elderly | TC, LDL-c, HDL-c, TG |
| Ramos 2013 [22] | Brazil | F | 22.8 ± 6.6 | Women with polycystic ovary syndrome | TC, LDL-c, HDL-c, TG |
| Gambino 2010 [23] | Caucasian, Italy | M/F | 54.2–54.7 | Population-based cohort | LDL-c, HDL-c |
| Cauchi 2007 [24] | Caucasian, French | M/F | Around 22 | Small gestational age, appropriate for gestational age birth weight | TC, TG |
| Cauchi 2006 [25] | French | M/F | 30–65 | Normoglycemic | TC, LDL-c, HDL-c, TG |
| Humphries 2006 [26] | European White, Indian Asia, Afro-Caribbean | M/F | 62.4–63 | Diabetic patients, healthy subjects | TC, LDL-c, HDL-c, TG |
| Bo 2009 [27] | Italy | M/F | 55.2–56.8 | Nondiabetic dysmetabolic participants, control | HDL-c, TG |
| Ereqat 2010 [28] | Palestinian | M/F | >40 ys | Diabetic subject, nondiabetic subjects | TC |
| Yan 2009 [29] | African American, Caucasian | M/F | 53-54 | The Atherosclerosis Risk in Communities Study (ARIC) | LDL-c, HDL-c, TG |
| Yan 2010 [30] | African American, Caucasian | M/F | 58.3–60.1 | The Atherosclerosis Risk in Communities Study (ARIC) | TC |
| Schroner 2011 [31] | Slovakia | M/F | 62.6–63.1 | Diabetic subject with HbA1C <7.0% | TC, LDL-c, HDL-c, TG |